ARCHIVES

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

NCI May Rent Chimps to Test AIDS Vaccines

November 29, 1985

DeVita, Greenwald Assure Centers They’ll Get More Money for Cancer Control

May 11, 1984

Varmus to NCAB: Budgetary “Haircuts” No Longer Sufficient to Cope With Fiscal Pressure

September 16, 2011

Funding Opportunities: March 1 Deadline For ACS Fellowships; Program Announcements

January 23, 1998

Fox Chase-U.Pa. Radiation Dept. Received Contract

October 12, 1979

Market Forces Changing Health Care System, Oncologists Told

June 2, 1995